Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 5
Submit an article Journal homepage
1,029
Views
12
CrossRef citations to date
0
Altmetric
Brief review

Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events

Mark S. JuhnPfizer Inc., New York, NY, USA
,
Bruce ParsonsPfizer Inc., New York, NY, USA
,
Roxanna VarvaraPfizer Inc., New York, NY, USA
&
Alesia SadoskyPfizer Inc., New York, NY, USA
Pages 1017-1026 | Accepted 13 Mar 2015, Published online: 01 Apr 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michael Serpell, Mark Latymer, Mary Almas, Marie Ortiz, Bruce Parsons & Rita Prieto. (2017) Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials. Journal of Pain Research 10, pages 1769-1776.
Read now
Lesley M. Arnold, Bill H. McCarberg, Andrew G. Clair, Ed Whalen, Neal Thomas, Anamaria Jorga, Lynne Pauer, Richard Vissing & Peter W. Park. (2017) Dose–response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. Postgraduate Medicine 129:8, pages 921-933.
Read now

Articles from other publishers (10)

Ken Munene Nkonge, Dennis Karani Nkonge & Teresa Njeri Nkonge. (2023) Screening for diabetic peripheral neuropathy in resource-limited settings. Diabetology & Metabolic Syndrome 15:1.
Crossref
Tingting Zhao, Chun Wang, Xinying Huo, Ming‐Liang He & Jinfei Chen. (2020) Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma. Journal of Cellular and Molecular Medicine 24:21, pages 12525-12536.
Crossref
Sascha R. A. Alles, Stuart M. Cain & Terrance P. Snutch. (2020) Pregabalin as a Pain Therapeutic: Beyond Calcium Channels. Frontiers in Cellular Neuroscience 14.
Crossref
Uazman Alam, Gordon Sloan & Solomon Tesfaye. (2020) Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. Drugs 80:4, pages 363-384.
Crossref
Joe AlexanderJrJr, Roger A. Edwards, Marina Brodsky, Alberto Savoldelli, Luigi Manca, Roberto Grugni, Birol Emir, Ed Whalen, Steve Watt & Bruce Parsons. (2019) Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy. Clinical Drug Investigation 39:8, pages 775-786.
Crossref
P. Ciaramitaro, G. Cruccu, M. de Tommaso, G. Devigili, D. Fornasari, P. Geppetti, M. Lacerenza, G. Lauria, S. Mameli, P. Marchettini, M. Nolano, E. Polati, V. Provitera, M. Romano, C. Solaro, S. Tamburin, V. Tugnoli, M. Valeriani & Andrea Truini. (2019) A Delphi consensus statement of the Neuropathic Pain Special Interest Group of the Italian Neurological Society on pharmacoresistant neuropathic pain. Neurological Sciences 40:7, pages 1425-1431.
Crossref
Joe AlexanderJrJr, Roger A. Edwards, Luigi Manca, Roberto Grugni, Gianluca Bonfanti, Birol Emir, Edward Whalen, Stephen Watt & Bruce Parsons. (2018) Dose Titration of Pregabalin in Patients with Painful Diabetic Peripheral Neuropathy: Simulation Based on Observational Study Patients Enriched with Data from Randomized Studies. Advances in Therapy 35:3, pages 382-394.
Crossref
J. A. Epps & N. A. Smart. (2016) Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration. Cardiovascular Diabetology 15:1.
Crossref
K. Asomaning, S. Abramsky, Q. Liu, X. Zhou, R. E. Sobel & S. Watt. (2016) Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database. International Journal of Clinical Practice 70:5, pages 380-388.
Crossref
Lihua Hong, Jian Zhang & Jianguo Shen. (2015) Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy. Journal of Diabetes and its Complications 29:8, pages 1283-1286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.